<DOC>
	<DOCNO>NCT02816944</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy endoscopic ultrasonography ( EUS ) guide laser ablation liver , pancreas , retroperitoneal tumor , investigator use preoperative postoperative US/CEUS/CT/MRI ass lesion , laboratory test include tumor marker evaluate general condition patient . Intraoperative US/CEUS/CT would apply monitor ablation lesion .</brief_summary>
	<brief_title>Effectivity Safety Endoscopic Ultrasonography-guided Laser Ablation Refractory Neoplasms</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Patients refractory neoplasms include small hepatocellular carcinoma adjacent gastrointestinal tract , pancreatic neuroendocrine tumor , retroperitoneal tumor le 3 cm diameter ; Patients ChildPugh A/B ; Patients PLT ≥ 50*10E9/L PT ≤ 20 . Patients severe cardiopulmonary disease , intolerant endoscopy anesthesia , upper gastrointestinal bleeding shock , corrosive esophagitis acute gastritis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Endoscopic ultrasonography</keyword>
	<keyword>Laser ablation</keyword>
</DOC>